| PaCIFiC-CUP Classifies Cancer of Unknown Primary (NCT06140992) | Sun Yat-sen University | 2023-07-01 |
| Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT (NCT05623267) | Sun Yat-sen University | 2023-07-01 |
| Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung Cancer (NCT05932264) | Sun Yat-sen University | 2023-07-01 |
| A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma (NCT05900765) | Sun Yat-sen University | 2023-06-14 |
| TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven Criteria (NCT05883176) | Sun Yat-sen University | 2023-06-01 |
| Effect of IOP Lowering on Progressive HM (NCT05850936) | Sun Yat-sen University | 2023-06-01 |
| Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults (NCT06363565) | Sun Yat-sen University | 2023-06-01 |
| Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma (NCT07644897) | Sun Yat-sen University | 2023-05-30 |
| HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial (NCT05886465) | Sun Yat-sen University | 2023-05-24 |
| Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma (NCT05877872) | Sun Yat-sen University | 2023-05-20 |
| Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer (NCT06451211) | Sun Yat-sen University | 2023-05-17 |
| Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases (NCT05807893) | Sun Yat-sen University | 2023-05-14 |
| HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC (NCT05866172) | Sun Yat-sen University | 2023-05-10 |
| Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer (NCT05824468) | Sun Yat-sen University | 2023-05-10 |
| Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer (NCT05824481) | Sun Yat-sen University | 2023-05-08 |
| Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma (NCT05913414) | Sun Yat-sen University | 2023-05-05 |
| The Effect of HPV Vaccine on Menstrual Cycle in Women of Reproductive Age (NCT05838157) | Sun Yat-sen University | 2023-05-04 |
| The Investigation of Knowledge and Educational Demand of Sexual and Reproductive Health Among Cancer Survivors (NCT05817981) | Sun Yat-sen University | 2023-05-01 |
| Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC (NCT05854849) | Sun Yat-sen University | 2023-05-01 |
| Effectiveness of an Interactive Consulting System to Enhance Patients' Decision-making: A Randomized Controlled Trial (NCT04262596) | Sun Yat-sen University | 2023-05-01 |
| Disitamab Vedotin Combined Therapy for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations (NCT05847764) | Sun Yat-sen University | 2023-05-01 |
| Construction and Validation of Risk Prediction Model for Gastrointestinal Dysfunction of Patient With Colorectal Cancer (NCT05891301) | Sun Yat-sen University | 2023-05-01 |
| A Conversational AI System to Enhance Knowledge About Vaccines and Promote Vaccination (NCT05689073) | Sun Yat-sen University | 2023-05-01 |
| Efficacy of Modified Fruquintinib in Colorectal Cancer Liver Metastases: A Phase II Study (NCT06018714) | Sun Yat-sen University | 2023-05-01 |
| A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer (NCT05742750) | Sun Yat-sen University | 2023-04-27 |
| Mechanism Exploration of Anti-HER-2 Small-molecule Tyrosine Kinase Inhibitor-related Diarrhea and Establishment of Prevention and Treatment Model(Measure) (NCT05773391) | Sun Yat-sen University | 2023-04-12 |
| The Risk Assessment Scale for Peripherally Inserted Central Venous Catheter (PICC) Related Thrombosis in Cancer Patients (NCT05977452) | Sun Yat-sen University | 2023-04-01 |
| Influence and Mechanism of Dyadic Coping on Parenting Stress and Parenting Self-Efficacy in Parents of Preterm Infant (NCT05592210) | Sun Yat-sen University | 2023-03-16 |
| Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases (NCT05768490) | Sun Yat-sen University | 2023-03-15 |
| Atezolizumab and Bevacizumab Plus TACE-HAIC for Unresectable Advanced HCC: a Phase 2 Clinical Trial (NCT05751343) | Sun Yat-sen University | 2023-03-09 |
| The Efficacy and Safety of Rifaximin Treatment (NCT05786859) | Sun Yat-sen University | 2023-03-09 |
| Neoadjuvant Toripalimab for dMMR/MSI-H Gastric Cancer (NCT05994456) | Sun Yat-sen University | 2023-03-09 |
| The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 Diabetes (NCT06127433) | Sun Yat-sen University | 2023-03-07 |
| Evaluation of COVID-19 Immune Barrier and Reinfection Risk (NCT05774093) | Sun Yat-sen University | 2023-03-06 |
| Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria) (NCT06090656) | Sun Yat-sen University | 2023-03-02 |
| Efficacy and Safety of BMSCs (CG-BM1) for ACLF Patients (NCT06740149) | Sun Yat-sen University | 2023-03-01 |
| SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH) (NCT05718232) | Sun Yat-sen University | 2023-03-01 |
| Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma (NCT06788353) | Sun Yat-sen University | 2023-03-01 |
| Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma (NCT05609695) | Sun Yat-sen University | 2023-03-01 |
| Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC (NCT05768503) | Sun Yat-sen University | 2023-03-01 |
| A Phase II Study of Rituximab, Chidamide, Zanubrutinib-induced and CHOP Therapy (NCT05527912) | Sun Yat-sen University | 2023-02-24 |
| Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell Carcinoma (NCT05760053) | Sun Yat-sen University | 2023-02-18 |
| PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC (NCT05737563) | Sun Yat-sen University | 2023-02-17 |
| Safety and Efficacy of Two-step Radical Prostatectomy (NCT05722392) | Sun Yat-sen University | 2023-02-15 |
| Steroid-Eluting Stent Implant for the Treatment of Radiation-Related Sinusitis (NCT05757479) | Sun Yat-sen University | 2023-02-11 |
| HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC (NCT07304388) | Sun Yat-sen University | 2023-02-10 |
| Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer (NCT05426005) | Sun Yat-sen University | 2023-02-07 |
| Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma (NCT05472948) | Sun Yat-sen University | 2023-02-01 |
| Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer. (NCT05749575) | Sun Yat-sen University | 2023-02-01 |
| Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer (NCT05775900) | Sun Yat-sen University | 2023-02-01 |
| Surufatinib Combined With TAS-102 in Third-line and Later-line Therapy of Patients With Advanced Pancreatic Cancer (NCT05481463) | Sun Yat-sen University | 2023-01-30 |
| Study on the Efficacy and Toxicity of Pamiparib Combined With Tamoxifen in the Treatment of Epithelial Ovarian Cancer Patients With Biochemical Recurrence During First-line PARPi Maintenance Therapy (NCT05669768) | Sun Yat-sen University | 2023-01-01 |
| AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING) (NCT05578430) | Sun Yat-sen University | 2023-01-01 |
| Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM) (NCT05848102) | Sun Yat-sen University | 2022-12-23 |
| Treatments for Brain Metastases With Poor Prognostic Factors (NCT05609162) | Sun Yat-sen University | 2022-12-15 |
| Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT05481476) | Sun Yat-sen University | 2022-12-12 |
| Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC (NCT05626569) | Sun Yat-sen University | 2022-12-10 |
| Artificial Intelligent System for Eye Emergency Triage and Primary Diagnosis (NCT05680090) | Sun Yat-sen University | 2022-12-10 |
| Artificial Intelligence-assisted Screening of Malignant Pigmented Tumors on the Ocular Surface (NCT05645341) | Sun Yat-sen University | 2022-12-05 |
| Validation of a Smartphone-based Intelligent Diagnosis and Measurement for Strabismus (NCT05615519) | Sun Yat-sen University | 2022-12-02 |
| A Real-World Study of COVID-19 Infection in Patients With Malignant Lymphomas Participating in Clinical Trials (NCT05827341) | Sun Yat-sen University | 2022-12-01 |
| Early Detection of noctUrnal hypoglyCemiA in TypE 2 Diabetes Using Pulse Rate Variability Measured by a Smartwatch(EDUCATED-Smartwatch) (NCT05636007) | Sun Yat-sen University | 2022-12-01 |
| A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy (NCT05622474) | Sun Yat-sen University | 2022-11-30 |
| SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma (NCT05524168) | Sun Yat-sen University | 2022-11-25 |
| The Association Between Watching Mukbang Videos and the Appetite of Children With Cancer (NCT05493020) | Sun Yat-sen University | 2022-11-24 |
| Influencing Factors and Trigger Mechanism of Relapse in Expectant Fathers Who Quit Smoking (NCT05474651) | Sun Yat-sen University | 2022-11-23 |
| Psychometric Properties of the Chinese Version of the Five-item Relationship Satisfaction Scale (NCT05494996) | Sun Yat-sen University | 2022-11-23 |
| Compression Therapy as a Prophylactic Method Against CIPN: a Prospective Self-controlled Trial (NCT05531916) | Sun Yat-sen University | 2022-11-21 |
| Combination of Local Therapy and Target Therapy for Brain Metastases With EGFR Mutation (NCT05616377) | Sun Yat-sen University | 2022-11-20 |
| Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors (NCT06206681) | Sun Yat-sen University | 2022-11-01 |
| PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101) (NCT05357846) | Sun Yat-sen University | 2022-11-01 |
| Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL Patients (NCT05577364) | Sun Yat-sen University | 2022-11-01 |
| Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid Tumors (NCT05620862) | Sun Yat-sen University | 2022-10-25 |
| A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents (NCT05718492) | Sun Yat-sen University | 2022-10-18 |
| Effect of Prebiotics on Blood Pressure Management (NCT05364736) | Sun Yat-sen University | 2022-10-17 |
| Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma (NCT05573282) | Sun Yat-sen University | 2022-10-16 |
| Comparison of Volume-controlled and Pressure-controlled Ventilation in Clasp-knife Position (NCT06056401) | Sun Yat-sen University | 2022-10-15 |
| Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN) (NCT05410197) | Sun Yat-sen University | 2022-10-10 |
| Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns (NCT06551220) | Sun Yat-sen University | 2022-10-10 |
| Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC (NCT05549466) | Sun Yat-sen University | 2022-10-08 |
| A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell Lymphoma (NCT05527275) | Sun Yat-sen University | 2022-10-01 |
| Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma (NCT05778955) | Sun Yat-sen University | 2022-10-01 |
| Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer (NCT05494580) | Sun Yat-sen University | 2022-09-22 |
| Concurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma（EC-CRT-003） (NCT05512520) | Sun Yat-sen University | 2022-09-20 |
| Safety and Efficacy of RX-af01 Combined With PD-1 Antibody (NCT05576961) | Sun Yat-sen University | 2022-09-15 |
| Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002) (NCT05520619) | Sun Yat-sen University | 2022-09-15 |
| CDK4/6 Inhibitor Plus Camrelizumab for PD-1 Inhibitor Refractory R/M NPC (NCT05724355) | Sun Yat-sen University | 2022-09-01 |
| Flexible Colonoscope Assisted Hybrid Transanal Total Mesorectal Resection (taTME) (NCT06380855) | Sun Yat-sen University | 2022-08-24 |
| Follow-up Strategy for Esophageal Cancer Patients (NCT06045715) | Sun Yat-sen University | 2022-08-20 |
| A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer (NCT05235906) | Sun Yat-sen University | 2022-08-16 |
| Correlation of Mukbang Video Watching Behavior,Internet Addition and Mental Health Among General Population (NCT05478408) | Sun Yat-sen University | 2022-08-15 |
| Ensartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 Mutation (NCT05491811) | Sun Yat-sen University | 2022-08-01 |
| Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients (NCT04508400) | Sun Yat-sen University | 2022-08-01 |
| FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients (NCT05727163) | Sun Yat-sen University | 2022-07-29 |
| Correlation of Mukbang Video Watching Behavior,Internet Addition and Mental Health Among Adolescent and Youth (NCT05478395) | Sun Yat-sen University | 2022-07-27 |
| HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study (NCT05476432) | Sun Yat-sen University | 2022-07-26 |
| Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM (NCT05485909) | Sun Yat-sen University | 2022-07-25 |
| Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody) (NCT05453435) | Sun Yat-sen University | 2022-07-15 |
| Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening (NCT05447169) | Sun Yat-sen University | 2022-07-10 |
| Phase II Study of TAEST16001 in Soft Tissue Sarcoma (NCT05549921) | Sun Yat-sen University | 2022-07-08 |